{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "Alpha",
      "COVID-19",
      "Coronavirus",
      "Gamma",
      "UV dosage",
      "UV-C",
      "Virus inactivation"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "34171342",
  "DateCompleted": {
    "Year": "2021",
    "Month": "07",
    "Day": "23"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "12",
    "Day": "17"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "06",
        "Day": "22"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/j.jviromet.2021.114216",
      "S0166-0934(21)00155-5"
    ],
    "Journal": {
      "ISSN": "1879-0984",
      "JournalIssue": {
        "Volume": "295",
        "PubDate": {
          "Year": "2021",
          "Month": "Sep"
        }
      },
      "Title": "Journal of virological methods",
      "ISOAbbreviation": "J Virol Methods"
    },
    "ArticleTitle": "Inactivation of SARS-CoV-2 isolates from lineages B.1.1.7 (Alpha), P.1 (Gamma) and B.1.110 by heating and UV irradiation.",
    "Pagination": {
      "StartPage": "114216",
      "MedlinePgn": "114216"
    },
    "Abstract": {
      "AbstractText": [
        "Currently, the rapid global spread of SARS-CoV-2 is related to G clade (including GH, GR, GRY and GV clades), which are associated with more than 98 % of sequenced viral isolates worldwide. The unprecedented velocity of spread of SARS-CoV-2 outbreak represents a critical need for prevention strategies. Vaccines are recently being available and antiviral drugs have shown limited efficacy in COVID-19 patients. Thus, it is needed to know how to reduce the infectivity of the virus by different physicochemical conditions in order to prevent exposure to contaminated material. This work describes heating and irradiating UV-C light procedures to reduce the infectivity of SARS-CoV-2 belonging to different three lineages. Results of physicochemical treatment showed no differences among viral lineages. Analytical conditions for efficient inactivation of SARS-CoV-2 were determined."
      ],
      "CopyrightInformation": "Copyright \u00a9 2021 Elsevier B.V. All rights reserved."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Molecular Genetics Sub Department, Institute of Public Health of Chile, Santiago, Chile."
          }
        ],
        "LastName": "Ulloa",
        "ForeName": "S",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Molecular Genetics Sub Department, Institute of Public Health of Chile, Santiago, Chile."
          }
        ],
        "LastName": "Bravo",
        "ForeName": "C",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Viral Diseases Sub Department, Institute of Public Health of Chile, Santiago, Chile."
          }
        ],
        "LastName": "Ramirez",
        "ForeName": "E",
        "Initials": "E"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Viral Diseases Sub Department, Institute of Public Health of Chile, Santiago, Chile."
          }
        ],
        "LastName": "Fasce",
        "ForeName": "R",
        "Initials": "R"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Molecular Genetics Sub Department, Institute of Public Health of Chile, Santiago, Chile. Electronic address: jfernand@ispch.cl."
          }
        ],
        "LastName": "Fernandez",
        "ForeName": "J",
        "Initials": "J"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Netherlands",
    "MedlineTA": "J Virol Methods",
    "NlmUniqueID": "8005839",
    "ISSNLinking": "0166-0934"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [
        "virology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Hot Temperature"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "genetics",
        "isolation & purification",
        "radiation effects"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Ultraviolet Rays"
    },
    {
      "QualifierName": [
        "radiation effects"
      ],
      "DescriptorName": "Virus Inactivation"
    }
  ],
  "CoiStatement": "The authors report no declarations of interest."
}